ArticleKorean journal of ophthalmology : KJO2025
Macular Edema in Diabetic Neovascular Glaucoma and Its Association with Systemic Diseases.
Article in Korean journal of ophthalmology : KJO, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeThis study assessed the development of macular edema (ME) and its association with systemic diseases in patients with diabetic neovascular glaucoma (NVG).
methodsThe medical records of 40 patients (45 eyes) diagnosed with diabetic NVG, between January 2017 and April 2022, were retrospectively reviewed. At the time of NVG diagnosis, central retinal thickness (CRT) was measured using optical coherence tomography. The eyes were categorized into groups with ME (CRT ≥300 μm) and without ME. Systemic diseases, ocular parameters, and prior treatments such as panretinal photocoagulation and intravitreal anti-vascular endothelial growth factor injections were compared between the two groups.
resultsOnly 6 of the 45 eyes (13.3%) had ME at the time of NVG diagnosis. No significant differences were observed between the ME and non-ME groups in terms of systemic diseases, including hypertension, hyperlipidemia, ischemic heart disease, cerebrovascular accident, and chronic kidney disease. Other clinical characteristics, such as age, sex, body mass index, smoking history, best-corrected visual acuity, intraocular pressure, lens status, and history of ocular treatment, were also comparable between groups.
conclusionsIn patients with diabetic NVG, ME was observed in a minority of cases and showed no significant association with systemic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.